Skip to main content
Top
Published in: Clinical Research in Cardiology 3/2024

21-04-2023 | Kidney Transplantation | Original Paper

Factors associated with changes in echocardiographic parameters following kidney transplantation

Authors: Q. d’Hervé, N. Girerd, E. Bozec, Z. Lamiral, V. Panisset, L. Frimat, O. Huttin, S. Girerd

Published in: Clinical Research in Cardiology | Issue 3/2024

Login to get access

Abstract

Background

Chronic kidney disease leads to cardiac remodelling of multifactorial origin known as “uraemic cardiomyopathy”, the reversibility of which after kidney transplantation (KT) remains controversial. Our objectives were to assess, in the modern era, changes in echocardiographic parameters following KT and identify predictive clinical and biological factors associated with echocardiographic changes.

Methods

One hundred six patients (mean age 48 ± 16, 73% male) who underwent KT at the University Hospital of Nancy between 2007 and 2018 were retrospectively investigated. Pre- and post-KT echocardiography findings (8.6 months before and 22 months after KT on average, respectively) were centralised, blind-reviewed and compared.

Results

A majority of patients (60%) had either a left ventricular (LV) ejection fraction < 50%, at least moderately abnormal LV mass index or left atrial (LA) dilatation at pretransplanted echocardiography. After KT, LV remodelling and diastolic doppler indices did not significantly change whereas LA volume index (LAVI) increased (35.9 mL/m2 post-KT vs. 30.9 mL/m2 pre-KT, p = 0.006). Advancing age, cardiac valvular disease, delayed graft function, lower post-KT haemoglobin, and more severe post-KT hypertension were associated with higher LAVI after KT. Higher post-KT serum creatinine, more severe post-KT hypertension and lower pre-KT blood calcium levels were associated with a deterioration in LAVI after KT.

Discussion/Conclusion

Adverse remodelling of the left atrial volume occurred after KT, predominantly in patients with lower pre-KT blood calcium, poorer graft function and post-KT hypertension. These results suggest that a better management of modifiable factors such as pre-KT hyperparathyroidism or post-KT hypertension could limit post-KT cardiac remodelling.

Graphical Abstract

Appendix
Available only for authorised users
Literature
2.
go back to reference Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M et al (2014) Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 383(9931):1831–1843PubMedCrossRef Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M et al (2014) Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 383(9931):1831–1843PubMedCrossRef
3.
go back to reference Wang X, Shapiro JI (2019) Evolving concepts in the pathogenesis of uraemic cardiomyopathy. Nat Rev Nephrol 15(3):159–175PubMedCrossRef Wang X, Shapiro JI (2019) Evolving concepts in the pathogenesis of uraemic cardiomyopathy. Nat Rev Nephrol 15(3):159–175PubMedCrossRef
4.
go back to reference Kaesler N, Babler A, Floege J, Kramann R (2020) Cardiac remodeling in chronic kidney disease. Toxins (Basel) 12(3):161PubMedCrossRef Kaesler N, Babler A, Floege J, Kramann R (2020) Cardiac remodeling in chronic kidney disease. Toxins (Basel) 12(3):161PubMedCrossRef
5.
go back to reference Mall G, Huther W, Schneider J, Lundin P, Ritz E (1990) Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 5(1):39–44PubMedCrossRef Mall G, Huther W, Schneider J, Lundin P, Ritz E (1990) Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 5(1):39–44PubMedCrossRef
6.
go back to reference Aoki J, Ikari Y, Nakajima H, Mori M, Sugimoto T, Hatori M et al (2005) Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int 67(1):333–340PubMedCrossRef Aoki J, Ikari Y, Nakajima H, Mori M, Sugimoto T, Hatori M et al (2005) Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int 67(1):333–340PubMedCrossRef
7.
8.
go back to reference Hamidi S, Kojuri J, Attar A, Roozbeh J, Moaref A, Nikoo MH (2018) The effect of kidney transplantation on speckled tracking echocardiography findings in patients on hemodialysis. J Cardiovasc Thorac Res 10(2):90–94PubMedPubMedCentralCrossRef Hamidi S, Kojuri J, Attar A, Roozbeh J, Moaref A, Nikoo MH (2018) The effect of kidney transplantation on speckled tracking echocardiography findings in patients on hemodialysis. J Cardiovasc Thorac Res 10(2):90–94PubMedPubMedCentralCrossRef
9.
go back to reference Hewing B, Dehn AM, Staeck O, Knebel F, Spethmann S, Stangl K et al (2016) Improved left ventricular structure and function after successful kidney transplantation. Kidney Blood Press Res 41(5):701–709PubMedCrossRef Hewing B, Dehn AM, Staeck O, Knebel F, Spethmann S, Stangl K et al (2016) Improved left ventricular structure and function after successful kidney transplantation. Kidney Blood Press Res 41(5):701–709PubMedCrossRef
10.
go back to reference Hawwa N, Shrestha K, Hammadah M, Yeo PSD, Fatica R, Tang WHW (2015) Reverse remodeling and prognosis following kidney transplantation in contemporary patients with cardiac dysfunction. J Am Coll Cardiol 66(16):1779–1787PubMedPubMedCentralCrossRef Hawwa N, Shrestha K, Hammadah M, Yeo PSD, Fatica R, Tang WHW (2015) Reverse remodeling and prognosis following kidney transplantation in contemporary patients with cardiac dysfunction. J Am Coll Cardiol 66(16):1779–1787PubMedPubMedCentralCrossRef
11.
go back to reference Vaidya OU, House JA, Coggins TR, Patil H, Vaidya A, Awad A et al (2012) Effect of renal transplantation for chronic renal disease on left ventricular mass. Am J Cardiol 110(2):254–257PubMedCrossRef Vaidya OU, House JA, Coggins TR, Patil H, Vaidya A, Awad A et al (2012) Effect of renal transplantation for chronic renal disease on left ventricular mass. Am J Cardiol 110(2):254–257PubMedCrossRef
12.
go back to reference Wali RK, Wang GS, Gottlieb SS, Bellumkonda L, Hansalia R, Ramos E et al (2005) Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol 45(7):1051–1060PubMedCrossRef Wali RK, Wang GS, Gottlieb SS, Bellumkonda L, Hansalia R, Ramos E et al (2005) Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol 45(7):1051–1060PubMedCrossRef
13.
go back to reference Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE et al (1995) Impact of renal transplantation on uremic cardiomyopathy. Transplantation 60(9):908–914PubMedCrossRef Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE et al (1995) Impact of renal transplantation on uremic cardiomyopathy. Transplantation 60(9):908–914PubMedCrossRef
14.
go back to reference Rigatto C, Foley RN, Kent GM, Guttmann R, Parfrey PS (2000) Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 70(4):570–575PubMedCrossRef Rigatto C, Foley RN, Kent GM, Guttmann R, Parfrey PS (2000) Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 70(4):570–575PubMedCrossRef
15.
go back to reference du Cailar G, Oudot C, Fesler P, Mimran A, Bonnet B, Pernin V et al (2014) Left ventricular mass changes after renal transplantation: influence of dietary sodium and change in serum uric acid. Transplantation 98(2):202–207PubMedCrossRef du Cailar G, Oudot C, Fesler P, Mimran A, Bonnet B, Pernin V et al (2014) Left ventricular mass changes after renal transplantation: influence of dietary sodium and change in serum uric acid. Transplantation 98(2):202–207PubMedCrossRef
16.
go back to reference Kensinger C, Hernandez A, Bian A, Fairchild M, Chen G, Lipworth L et al (2017) Longitudinal assessment of cardiac morphology and function following kidney transplantation. Clin Transplant 31(1):e12864CrossRef Kensinger C, Hernandez A, Bian A, Fairchild M, Chen G, Lipworth L et al (2017) Longitudinal assessment of cardiac morphology and function following kidney transplantation. Clin Transplant 31(1):e12864CrossRef
17.
go back to reference Zapolski T, Furmaga J, Wysokinski AP, Wysocka A, Rudzki S, Jaroszynski A (2019) The atrial uremic cardiomyopathy regression in patients after kidney transplantation—the prospective echocardiographic study. BMC Nephrol 20(1):152PubMedPubMedCentralCrossRef Zapolski T, Furmaga J, Wysokinski AP, Wysocka A, Rudzki S, Jaroszynski A (2019) The atrial uremic cardiomyopathy regression in patients after kidney transplantation—the prospective echocardiographic study. BMC Nephrol 20(1):152PubMedPubMedCentralCrossRef
18.
go back to reference McGregor E, Stewart G, Rodger RS, Jardine AG (2000) Early echocardiographic changes and survival following renal transplantation. Nephrol Dial Transplant 15(1):93–98PubMedCrossRef McGregor E, Stewart G, Rodger RS, Jardine AG (2000) Early echocardiographic changes and survival following renal transplantation. Nephrol Dial Transplant 15(1):93–98PubMedCrossRef
19.
go back to reference Patel RK, Mark PB, Johnston N, McGregor E, Dargie HJ, Jardine AG (2008) Renal transplantation is not associated with regression of left ventricular hypertrophy: a magnetic resonance study. Clin J Am Soc Nephrol 3(6):1807–1811PubMedPubMedCentralCrossRef Patel RK, Mark PB, Johnston N, McGregor E, Dargie HJ, Jardine AG (2008) Renal transplantation is not associated with regression of left ventricular hypertrophy: a magnetic resonance study. Clin J Am Soc Nephrol 3(6):1807–1811PubMedPubMedCentralCrossRef
20.
go back to reference Himelman RB, Landzberg JS, Simonson JS, Amend W, Bouchard A, Merz R et al (1988) Cardiac consequences of renal transplantation: changes in left ventricular morphology and function. J Am Coll Cardiol 12(4):915–923PubMedCrossRef Himelman RB, Landzberg JS, Simonson JS, Amend W, Bouchard A, Merz R et al (1988) Cardiac consequences of renal transplantation: changes in left ventricular morphology and function. J Am Coll Cardiol 12(4):915–923PubMedCrossRef
21.
go back to reference Hernandez D, Lacalzada J, Rufino M, Torres A, Martin N, Barragan A et al (1997) Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene. Kidney Int 51(4):1205–1211PubMedCrossRef Hernandez D, Lacalzada J, Rufino M, Torres A, Martin N, Barragan A et al (1997) Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene. Kidney Int 51(4):1205–1211PubMedCrossRef
22.
go back to reference Keven K, Calayoglu R, Sengul S, Dincer I, Kutlay S, Erturk S et al (2008) Comparative effects of renal transplantation and maintenance dialysis on arterial stiffness and left ventricular mass index. Clin Transplant 22(3):360–365PubMedCrossRef Keven K, Calayoglu R, Sengul S, Dincer I, Kutlay S, Erturk S et al (2008) Comparative effects of renal transplantation and maintenance dialysis on arterial stiffness and left ventricular mass index. Clin Transplant 22(3):360–365PubMedCrossRef
23.
go back to reference Sahagun-Sanchez G, Espinola-Zavaleta N, Lafragua-Contreras M, Chavez PY, Gomez-Nunez N, Keirns C et al (2001) The effect of kidney transplant on cardiac function: an echocardiographic perspective. Echocardiography 18(6):457–462PubMedCrossRef Sahagun-Sanchez G, Espinola-Zavaleta N, Lafragua-Contreras M, Chavez PY, Gomez-Nunez N, Keirns C et al (2001) The effect of kidney transplant on cardiac function: an echocardiographic perspective. Echocardiography 18(6):457–462PubMedCrossRef
24.
go back to reference Pickup LC, Law JP, Radhakrishnan A, Price AM, Loutradis C, Smith TO et al (2021) Changes in left ventricular structure and function associated with renal transplantation: a systematic review and meta-analysis. ESC Heart Fail 8(3):2045–2057PubMedPubMedCentralCrossRef Pickup LC, Law JP, Radhakrishnan A, Price AM, Loutradis C, Smith TO et al (2021) Changes in left ventricular structure and function associated with renal transplantation: a systematic review and meta-analysis. ESC Heart Fail 8(3):2045–2057PubMedPubMedCentralCrossRef
25.
go back to reference De Lima JJ, Abensur H, da Fonseca JA, Krieger EM, Pileggi F (1995) Comparison of echocardiographic changes associated with hemodialysis and renal transplantation. Artif Organs 19(3):245–250PubMedCrossRef De Lima JJ, Abensur H, da Fonseca JA, Krieger EM, Pileggi F (1995) Comparison of echocardiographic changes associated with hemodialysis and renal transplantation. Artif Organs 19(3):245–250PubMedCrossRef
26.
go back to reference Prasad GVR, Yan AT, Nash MM, Kim SJ, Wald R, Lok C et al (2018) Determinants of left ventricular characteristics assessed by cardiac magnetic resonance imaging and cardiovascular biomarkers related to kidney transplantation. Can J Kidney Health Dis 5:2054358118809974PubMedCrossRef Prasad GVR, Yan AT, Nash MM, Kim SJ, Wald R, Lok C et al (2018) Determinants of left ventricular characteristics assessed by cardiac magnetic resonance imaging and cardiovascular biomarkers related to kidney transplantation. Can J Kidney Health Dis 5:2054358118809974PubMedCrossRef
28.
go back to reference Karras A, Boutouyrie P, Briet M, Bozec E, Haymann JP, Legendre C et al (2017) Reversal of arterial stiffness and maladaptative arterial remodeling after kidney transplantation. J Am Heart Assoc 6(9):e006078PubMedPubMedCentralCrossRef Karras A, Boutouyrie P, Briet M, Bozec E, Haymann JP, Legendre C et al (2017) Reversal of arterial stiffness and maladaptative arterial remodeling after kidney transplantation. J Am Heart Assoc 6(9):e006078PubMedPubMedCentralCrossRef
29.
go back to reference Haller MC, Kammer M, Oberbauer R (2019) Dialysis vintage and outcomes in renal transplantation. Nephrol Dial Transplant 34(4):555–560PubMedCrossRef Haller MC, Kammer M, Oberbauer R (2019) Dialysis vintage and outcomes in renal transplantation. Nephrol Dial Transplant 34(4):555–560PubMedCrossRef
30.
go back to reference Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH et al (2021) Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 99(3):559–569PubMedCrossRef Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH et al (2021) Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 99(3):559–569PubMedCrossRef
31.
go back to reference Kidney Disease: Improving Global Outcomes Diabetes Work G (2022) KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 102(5S):S1–S127 Kidney Disease: Improving Global Outcomes Diabetes Work G (2022) KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 102(5S):S1–S127
32.
go back to reference Wanner C, Tonelli M, Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group M (2014) KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int 85(6):1303–1309PubMedCrossRef Wanner C, Tonelli M, Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group M (2014) KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int 85(6):1303–1309PubMedCrossRef
33.
go back to reference Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16(3):233–270PubMedCrossRef Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16(3):233–270PubMedCrossRef
34.
go back to reference Pellicori P, Ferreira JP, Mariottoni B, Brunner-La Rocca HP, Ahmed FZ, Verdonschot J et al (2020) Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. Eur J Heart Fail 22(9):1711–1723PubMedCrossRef Pellicori P, Ferreira JP, Mariottoni B, Brunner-La Rocca HP, Ahmed FZ, Verdonschot J et al (2020) Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. Eur J Heart Fail 22(9):1711–1723PubMedCrossRef
35.
go back to reference Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1-39 e14PubMedCrossRef Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1-39 e14PubMedCrossRef
36.
go back to reference Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277–314PubMedCrossRef Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277–314PubMedCrossRef
37.
go back to reference Khani M, Tara A, Shekarkhar S, Esfahani MA, Bayat F (2020) Effect of kidney transplantation on right ventricular function, assessment by 2- dimensional speckle tracking echocardiography. Cardiovasc Ultrasound 18(1):16PubMedPubMedCentralCrossRef Khani M, Tara A, Shekarkhar S, Esfahani MA, Bayat F (2020) Effect of kidney transplantation on right ventricular function, assessment by 2- dimensional speckle tracking echocardiography. Cardiovasc Ultrasound 18(1):16PubMedPubMedCentralCrossRef
38.
go back to reference Casas-Aparicio G, Castillo-Martinez L, Orea-Tejeda A, Abasta-Jimenez M, Keirns-Davies C, Rebollar-Gonzalez V (2010) The effect of successful kidney transplantation on ventricular dysfunction and pulmonary hypertension. Transplant Proc 42(9):3524–3528PubMedCrossRef Casas-Aparicio G, Castillo-Martinez L, Orea-Tejeda A, Abasta-Jimenez M, Keirns-Davies C, Rebollar-Gonzalez V (2010) The effect of successful kidney transplantation on ventricular dysfunction and pulmonary hypertension. Transplant Proc 42(9):3524–3528PubMedCrossRef
39.
go back to reference Meucci MC, Reinders MEJ, Groeneweg KE, Bezstarosti S, Ajmone Marsan N, Bax JJ et al (2021) Cardiovascular effects of autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal in renal transplant recipients: an analysis of the randomized TRITON study. J Am Heart Assoc 10(24):e023300PubMedPubMedCentralCrossRef Meucci MC, Reinders MEJ, Groeneweg KE, Bezstarosti S, Ajmone Marsan N, Bax JJ et al (2021) Cardiovascular effects of autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal in renal transplant recipients: an analysis of the randomized TRITON study. J Am Heart Assoc 10(24):e023300PubMedPubMedCentralCrossRef
40.
go back to reference Hernandez D, Gonzalez A, Rufino M, Laynez I, de la Rosa A, Porrini E et al (2007) Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass. Nephrol Dial Transplant 22(9):2678–2685PubMedCrossRef Hernandez D, Gonzalez A, Rufino M, Laynez I, de la Rosa A, Porrini E et al (2007) Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass. Nephrol Dial Transplant 22(9):2678–2685PubMedCrossRef
41.
go back to reference Huting J (1992) Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation. Am J Cardiol 70(18):1481–1484PubMedCrossRef Huting J (1992) Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation. Am J Cardiol 70(18):1481–1484PubMedCrossRef
42.
go back to reference Thomas L, Muraru D, Popescu BA, Sitges M, Rosca M, Pedrizzetti G et al (2020) Evaluation of left atrial size and function: relevance for clinical practice. J Am Soc Echocardiogr 33(8):934–952PubMedCrossRef Thomas L, Muraru D, Popescu BA, Sitges M, Rosca M, Pedrizzetti G et al (2020) Evaluation of left atrial size and function: relevance for clinical practice. J Am Soc Echocardiogr 33(8):934–952PubMedCrossRef
43.
44.
go back to reference Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET et al (2006) Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 151(2):412–418PubMedCrossRef Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET et al (2006) Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 151(2):412–418PubMedCrossRef
45.
go back to reference Kadappu KK, Abhayaratna K, Boyd A, French JK, Xuan W, Abhayaratna W et al (2016) Independent echocardiographic markers of cardiovascular involvement in chronic kidney disease: the value of left atrial function and volume. J Am Soc Echocardiogr 29(4):359–367PubMedCrossRef Kadappu KK, Abhayaratna K, Boyd A, French JK, Xuan W, Abhayaratna W et al (2016) Independent echocardiographic markers of cardiovascular involvement in chronic kidney disease: the value of left atrial function and volume. J Am Soc Echocardiogr 29(4):359–367PubMedCrossRef
46.
go back to reference Tanasa A, Tapoi L, Ureche C, Sascau R, Statescu C, Covic A (2021) Left atrial strain: a novel “biomarker” for chronic kidney disease patients? Echocardiography 38(12):2077–2082PubMedCrossRef Tanasa A, Tapoi L, Ureche C, Sascau R, Statescu C, Covic A (2021) Left atrial strain: a novel “biomarker” for chronic kidney disease patients? Echocardiography 38(12):2077–2082PubMedCrossRef
47.
go back to reference Patel RK, Pennington C, Stevens KK, Taylor A, Gillis K, Rutherford E et al (2014) Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome-a single-center study. Transplant Res 3(1):20PubMedPubMedCentralCrossRef Patel RK, Pennington C, Stevens KK, Taylor A, Gillis K, Rutherford E et al (2014) Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome-a single-center study. Transplant Res 3(1):20PubMedPubMedCentralCrossRef
48.
go back to reference Kainz A, Goliasch G, Wiesbauer F, Binder T, Maurer G, Nesser HJ et al (2013) Left atrial diameter and survival among renal allograft recipients. Clin J Am Soc Nephrol 8(12):2100–2105PubMedPubMedCentralCrossRef Kainz A, Goliasch G, Wiesbauer F, Binder T, Maurer G, Nesser HJ et al (2013) Left atrial diameter and survival among renal allograft recipients. Clin J Am Soc Nephrol 8(12):2100–2105PubMedPubMedCentralCrossRef
50.
go back to reference Reinders MEJ, Groeneweg KE, Hendriks SH, Bank JR, Dreyer GJ, de Vries APJ et al (2021) Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study. Am J Transplant 21(9):3055–3065PubMedPubMedCentralCrossRef Reinders MEJ, Groeneweg KE, Hendriks SH, Bank JR, Dreyer GJ, de Vries APJ et al (2021) Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study. Am J Transplant 21(9):3055–3065PubMedPubMedCentralCrossRef
51.
go back to reference Meucci MC, Reinders MEJ, Groeneweg KE, Bezstarosti S, Marsan NA, Bax JJ et al (2023) Left atrial structural and functional response in kidney transplant recipients treated with mesenchymal stromal cell therapy and early tacrolimus withdrawal. J Am Soc Echocardiogr 36(2):172–179PubMedCrossRef Meucci MC, Reinders MEJ, Groeneweg KE, Bezstarosti S, Marsan NA, Bax JJ et al (2023) Left atrial structural and functional response in kidney transplant recipients treated with mesenchymal stromal cell therapy and early tacrolimus withdrawal. J Am Soc Echocardiogr 36(2):172–179PubMedCrossRef
52.
go back to reference Lee SL, Daimon M, Nakao T, Singer DE, Shinozaki T, Kawata T et al (2016) Factors influencing left atrial volume in a population with preserved ejection fraction: left ventricular diastolic dysfunction or clinical factors? J Cardiol 68(4):275–281PubMedCrossRef Lee SL, Daimon M, Nakao T, Singer DE, Shinozaki T, Kawata T et al (2016) Factors influencing left atrial volume in a population with preserved ejection fraction: left ventricular diastolic dysfunction or clinical factors? J Cardiol 68(4):275–281PubMedCrossRef
53.
go back to reference Dereli S, Bayramoglu A, Ozer N, Cersit S, Kaya A, Ozbilen M (2019) Evaluation of left atrial volume and function by real time three-dimensional echocardiography in anemic patients without overt heart disease before and after anemia correction. Int J Cardiovasc Imaging 35(9):1619–1626PubMedCrossRef Dereli S, Bayramoglu A, Ozer N, Cersit S, Kaya A, Ozbilen M (2019) Evaluation of left atrial volume and function by real time three-dimensional echocardiography in anemic patients without overt heart disease before and after anemia correction. Int J Cardiovasc Imaging 35(9):1619–1626PubMedCrossRef
54.
go back to reference Beysel S, Caliskan M, Kizilgul M, Apaydin M, Kan S, Ozbek M et al (2019) Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord 19(1):106PubMedPubMedCentralCrossRef Beysel S, Caliskan M, Kizilgul M, Apaydin M, Kan S, Ozbek M et al (2019) Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord 19(1):106PubMedPubMedCentralCrossRef
55.
go back to reference Andersson P, Rydberg E, Willenheimer R (2004) Primary hyperparathyroidism and heart disease–a review. Eur Heart J 25(20):1776–1787PubMedCrossRef Andersson P, Rydberg E, Willenheimer R (2004) Primary hyperparathyroidism and heart disease–a review. Eur Heart J 25(20):1776–1787PubMedCrossRef
56.
go back to reference Purra S, Lone AA, Bhat MH, Misgar RA, Wani AI, Bashir MI et al (2022) Cardiac structural and functional abnormalities in primary hyperparathyroidism. J Endocrinol Invest 45(2):327–335PubMedCrossRef Purra S, Lone AA, Bhat MH, Misgar RA, Wani AI, Bashir MI et al (2022) Cardiac structural and functional abnormalities in primary hyperparathyroidism. J Endocrinol Invest 45(2):327–335PubMedCrossRef
57.
go back to reference Kepez A, Yasar M, Sunbul M, Ileri C, Deyneli O, Mutlu B et al (2017) Evaluation of left ventricular functions in patients with primary hyperparathyroidism: is there any effect of parathyroidectomy? Wien Klin Wochenschr 129(9–10):329–336PubMedCrossRef Kepez A, Yasar M, Sunbul M, Ileri C, Deyneli O, Mutlu B et al (2017) Evaluation of left ventricular functions in patients with primary hyperparathyroidism: is there any effect of parathyroidectomy? Wien Klin Wochenschr 129(9–10):329–336PubMedCrossRef
58.
go back to reference Isakov O, Ghinea R, Beckerman P, Mor E, Riella LV, Hod T (2020) Early persistent hyperparathyroidism post-renal transplantation as a predictor of worse graft function and mortality after transplantation. Clin Transplant 34(11):e14085PubMedCrossRef Isakov O, Ghinea R, Beckerman P, Mor E, Riella LV, Hod T (2020) Early persistent hyperparathyroidism post-renal transplantation as a predictor of worse graft function and mortality after transplantation. Clin Transplant 34(11):e14085PubMedCrossRef
Metadata
Title
Factors associated with changes in echocardiographic parameters following kidney transplantation
Authors
Q. d’Hervé
N. Girerd
E. Bozec
Z. Lamiral
V. Panisset
L. Frimat
O. Huttin
S. Girerd
Publication date
21-04-2023

Other articles of this Issue 3/2024

Clinical Research in Cardiology 3/2024 Go to the issue